News Conference News TCT 2017 DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients Michael O'Riordan November 01, 2017
News Conference News TCT 2017 Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year Yael L. Maxwell October 30, 2017
News Conference News VIVA 2017 Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD L.A. McKeown September 18, 2017
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
News Conference News ESC 2017 BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months Shelley Wood August 30, 2017
News Conference News EuroPCR 2017 Slimmest Stent to Date Looks Promising in Small Study Shelley Wood May 19, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Conference News ISET 2017 Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs? Caitlin E. Cox February 17, 2017
News Conference News ISET 2017 Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial Caitlin E. Cox February 15, 2017